Surgery pp 1525-1533 | Cite as

Thoracic and Pulmonary Infections

  • Frank A. BaciewiczJr.


All surgical specialties spend considerable effort to prevent lung infections from occurring and unfortunately even more resources once they have occurred. Due to the often immune-compromised status of surgical patients, the hospital environment, and the infectious nature of many surgical diseases, the surgeon must be vigilant in the diagnosis and treatment of infectious processes of the lung. This chapter outlines the diagnosis, possible preventive measures, and treatment of both common and less-common thoracic infections.


Respir Crit Nosocomial Pneumonia Pleural Space Open Lung Biopsy Bronchopleural Fistula 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Centers for Disease Control. Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ 1986;35(ISS):17.Google Scholar
  2. 2.
    Barrett FF, Casey JI, Finland M. Infections and antibiotic use among patients at Boston City Hospital, February 1967. N Engl J Med 1968;278:5.PubMedGoogle Scholar
  3. 3.
    Gross PA, Neu HC, Aswapokee P, et al. Deaths from nosocomial infection: experience in a university and community hospital. Am J Med 1980;68:219.PubMedCrossRefGoogle Scholar
  4. 4.
    Stevens RM, Teres D, Skillman JJ, et al. Pneumonia in an intensive care unit. A 30 month experience. Arch Intern Med 1974;134:106.PubMedCrossRefGoogle Scholar
  5. 5.
    Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1986;133:792.PubMedGoogle Scholar
  6. 6.
    Fagan JY, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Am Rev Respir Dis 1989;139:877.Google Scholar
  7. 7.
    Lee SC, Hua CC, Yu TJ, et al. Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy. Int J Clin Pract 2005;59:39–45.PubMedCrossRefGoogle Scholar
  8. 8.
    Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 2004;32:2183–2190.PubMedGoogle Scholar
  9. 9.
    Hugonnet S, Eggimann P, Borst F, et al. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol 2004;25:1090–1096.PubMedCrossRefGoogle Scholar
  10. 10.
    Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure: a randomized prospective study. JAMA 1979;242:2193.PubMedCrossRefGoogle Scholar
  11. 11.
    Centers for Disease Control. Nosocomial infection surveillance, 1984. MMWR Morb Mortal Wkly Rep 1986;35:17SS.Google Scholar
  12. 12.
    Centers for Disease Control. Nosocomial infections 1980–1982. MMWR Morb Mortal Wkly Rep 1983;32:1SS.Google Scholar
  13. 13.
    Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969;281:1137.PubMedGoogle Scholar
  14. 14.
    Johanson WG, Pierce AK, Sandford JP. Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of infections of the respiratory tract. Ann Intern Med 1972;77:701.PubMedGoogle Scholar
  15. 15.
    Brennan MT, Bahrani-Mougeot F, Fox PC. The role of oral microbial colonization in ventilator-associated pneumonia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004;98:665–672.PubMedCrossRefGoogle Scholar
  16. 16.
    Hillman KM, Riordan T, O’Farrell SM, et al. Colonization of the gastric content in critically ill patients. Crit Care Med 1982;10:444.PubMedGoogle Scholar
  17. 17.
    Kahn RJ, Brimioulle S, Vincent JL. Influence of antacid treatment on the tracheal flora in mechanically ventilated patients. Crit Care Med 1982;10:229.CrossRefGoogle Scholar
  18. 18.
    Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med 1987;317:1376.PubMedGoogle Scholar
  19. 19.
    Palmer RH, Gachot B, Jebrak G, et al. Nosocomial pneumonia in intubated patients. N Engl J Med 1988;318:1465.Google Scholar
  20. 20.
    Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359–1367.PubMedCrossRefGoogle Scholar
  21. 21.
    Andrews CP, Coalson JJ, Smith JD, et al. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury. Chest 1981;80:254.PubMedCrossRefGoogle Scholar
  22. 22.
    Fagan JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients: use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis 1988;138:110.Google Scholar
  23. 23.
    Carlson RW, Geheb MA. Pneumonia. In: Principles and Practice of Medical Intensive Care. Philadelphia: Saunders; 1993:481.Google Scholar
  24. 24.
    Davis KA, Eckert MJ, Reed RL 2nd, et al. Ventilator-associated pneumonia in injured patients: do you trust your Gram’s stain? J Trauma 2005;58:462–467.PubMedCrossRefGoogle Scholar
  25. 25.
    Cook DJ, Brun-Buisson C, Guyatt GH, et al. Evaluation of new diagnostic technologies: bronchoalveolar lavage and the diagnosis of ventilator-associated pneumonia. Crit Care Med 1994;22:1314–1322.PubMedCrossRefGoogle Scholar
  26. 26.
    Rouby JJ, Rossignon MD, Nicolas MH, et al. A prospective study of protected bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. Anesthesiology 1989;7:679.CrossRefGoogle Scholar
  27. 27.
    Shorr AF, Sherner JH, Jackson WL. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005;33:46–53.PubMedCrossRefGoogle Scholar
  28. 28.
    Chastre J, Fagon J. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;154:867–903.Google Scholar
  29. 29.
    Torres A, Ewig S. Diagnosing ventilator-associated pneumonia. N Engl J Med 2004;35:433–435.CrossRefGoogle Scholar
  30. 30.
    Ost DE, Hall CS, Jospeh G, et al. Decision analysis of antibiotic and diagnostic strategies in ventilator-associated pneumonia. Am J Respir Crit Care Med 2003;168:1060–1067.PubMedCrossRefGoogle Scholar
  31. 31.
    Wood AY, Davit AJ 2nd, Ciraulo DL. A prospective assessment of diagnostic efficacy of blind protective bronchial brushing compared to bronchoscope-assisted lavage, bronchoscope directed brushings, and blind endotracheal aspirates in ventilator-associated pneumonia. J Trauma 2003;55:825–834.PubMedCrossRefGoogle Scholar
  32. 32.
    Grossman RF, Fein A. Evidence-based assessment of diagnostic tests for ventilator-associated pneumonia. Chest 2000;117:177S–181S.PubMedCrossRefGoogle Scholar
  33. 33.
    Dijkman JH, van der Meer JWM, Bakker W, et al. Transpleural lung biopsy by the thoracoscopic route in patients with diffuse interstitial pulmonary disease. Chest 1982;82:76.PubMedCrossRefGoogle Scholar
  34. 34.
    McCabe RE, Brooks RG, Mark JBD, et al. Open lung biopsy in patients with acute leukemia. Am J Med 1985;78:609.PubMedCrossRefGoogle Scholar
  35. 35.
    Craven DE, Kunches LM, Lichtenberg DA, et al. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988;148:1161.PubMedCrossRefGoogle Scholar
  36. 36.
    Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in medical intensive care units in the United States National Nosocomial Infections Surveillance System. Crit Care Med 1999;27:887–892.PubMedCrossRefGoogle Scholar
  37. 37.
    El-Solh AA, Aquilina AT, Dhillon RS, et al. Impact of invasive strategy on management of antimicrobial treatment failure in institutionalized older people with severe pneumonia. Am J Respir Crit Care Med 2002;166:1038–1043.PubMedCrossRefGoogle Scholar
  38. 38.
    Centers for Disease Control: Nosocomial infection surveillance: 1983. MMWR CDC Surveill Summ 1984;33(2SS):9.Google Scholar
  39. 39.
    American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired ventilator-assisted, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388–416.CrossRefGoogle Scholar
  40. 40.
    Thompson DS. Methicillin-resistant Staphylococcus aureus in a general intensive care unit. J R Soc Med 2004;97:521–526.PubMedCrossRefGoogle Scholar
  41. 41.
    Shorr AF, Susla GB, Kollef MH. Quinolones for treatment of nosocomial pneumonia: a meta-analysis. Clin Infect Dis 2005;40:115–122.CrossRefGoogle Scholar
  42. 42.
    Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest 1978;74:170.PubMedCrossRefGoogle Scholar
  43. 43.
    Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980;69:507.PubMedCrossRefGoogle Scholar
  44. 44.
    Andrews NC, Parker EF, Shaw RR, et al. Management of nontuberculous empyema. Am Rev Respir Dis 1962;85:935.Google Scholar
  45. 45.
    Sahn SA, Reller LB, Taryle DA, et al. The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis 1983;128:811.PubMedGoogle Scholar
  46. 46.
    Light RW, Moller DJ Jr, George RB. Low pleural fluid pH in parapneumonic effusion. Chest 1975;68:273.PubMedCrossRefGoogle Scholar
  47. 47.
    Collins JD, Burwell D, Furmanski S, et al. Minimal detectable pleural effusions. Radiology 1972;105:51.Google Scholar
  48. 48.
    Roch A, Bojan M, Michelet P, et al. Usefulness of ultrasonography in predicting pleural effusions >500mL in patients receiving mechanical ventilation. Chest 2005;127:224–232.PubMedCrossRefGoogle Scholar
  49. 49.
    Stark DD, Federle MP, Goodman PC, et al. Differentiating lung abscess and empyema: radiography and computed tomography. AJR Am J Roentgenol 1983;141:163.PubMedGoogle Scholar
  50. 50.
    Sahn SA. State of the art: the pleural. Am Rev Respir Dis 1988:138:184.PubMedGoogle Scholar
  51. 51.
    Light RW, George RB. Incidence and significance of pleural effusion after abdominal surgery. Chest 1976;69:621.PubMedCrossRefGoogle Scholar
  52. 52.
    Nielsen PH, Jepsen SB, Olsen AD. Postoperative pleural effusion following upper abdominal surgery. Chest 1989;96:133.CrossRefGoogle Scholar
  53. 53.
    McKenna J, Craig RM, Chandraseekhar AJ, et al. The pleuropulmonary complication of pancreatitis. Chest 1977;71:197.PubMedCrossRefGoogle Scholar
  54. 54.
    Light RW, Girard WM, Jenkinson SG, et al. Parapneumonic effusions. Am J Med 1980;69:507.PubMedCrossRefGoogle Scholar
  55. 55.
    Klein JS, Schultz S, Heffner JE. Interventional radiology of the chest: image-guided percutaneous drainage of pleural effusions, lung abscess and pneumothorax. AJR Am J Roentgenol 1995;164:581–588.PubMedGoogle Scholar
  56. 56.
    Ulmer JL, Choplin RH, Reed JC. Image-guided catheter drainage of the infected pleural space. J Thorac Imaging 1991;6:65–73.PubMedCrossRefGoogle Scholar
  57. 57.
    Bergh NP, Ekroth R, Larsson S, et al. Intrapleural streptokinase in the treatment of haemothorax and empyema. Scand J Thorac Cardiovasc Surg 1977;11:265.PubMedGoogle Scholar
  58. 58.
    Willsie-Ediger SK, Salzman G, Reisz G, et al. Use of intrapleural streptokinase in the treatment of thoracic empyema. Am J Med 1990;300:296.CrossRefGoogle Scholar
  59. 59.
    Park CS, Chung WM, Lim MK, et al. Transcatheter instillation of urokinase into loculated pleural effusion: analysis of treatment effect. AJR Am J Roentgenol 1996;167:649–652.PubMedGoogle Scholar
  60. 60.
    Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997;52:416–421.PubMedGoogle Scholar
  61. 61.
    Basile A, Boullosa-Seoane E, et al. Intrapleural fibrinolysis in the management of empyemas and haemothoraces. Our experience. Radiol Med 2003;105:12–16.PubMedGoogle Scholar
  62. 62.
    Bouros D, Antoniou KM, Chalkiadakis G, et al. The role of video-assisted thoracoscopic surgery in the treatment of parapneumonic empyema after the failure of fibrinolytics. Surg Endosc 2002;Epub 2001.Google Scholar
  63. 63.
    Diacon AH, Theron J, Schuurmans MM, et al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004;170:49–53.PubMedCrossRefGoogle Scholar
  64. 64.
    Renzetti AD. Current treatment of nontuberculous empyema. Pulmonary Perspectives 1986;34:1.Google Scholar
  65. 65.
    Leblan KA, Tucker WY. Empyema of the thorax. Surg Gynecol 1984;158:66.Google Scholar
  66. 66.
    Muskett A, Burton NA, Karwande SV, et al. Management of refractory empyema with early decortication. Am J Surg 1988;156:529.PubMedCrossRefGoogle Scholar
  67. 67.
    Eloesser L. Of an operation for tuberculosis empyema. Ann Thorac Surg 1969;8:355.PubMedCrossRefGoogle Scholar
  68. 68.
    Centers for Disease Control. Summary of notifiable diseases, United States, 1989. MMWR Morb Mortal Wkly Rep 1989;38:43.Google Scholar
  69. 69.
    Bloch AB, Reider HL, Kelly GD, et al. The epidemiology of tuberculosis in the United States. Clin Chest Med 1989;10:297.PubMedGoogle Scholar
  70. 70.
    Chaisson Re, Schecter GF, Theuer CP, et al. Tuberculosis in patients with acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis 1987;136:570.PubMedGoogle Scholar
  71. 71.
    Rieder HL, Cauthen GM, Kelly GD, et al. Tuberculosis in the United States. JAMA 1989;262:385.PubMedCrossRefGoogle Scholar
  72. 72.
    Stead WW, Lofgren JP, Warren E, et al. Tuberculosis as an endemic and nosocomial infection among the elderly in nursing homes. N Engl J Med 1985;312:1483.PubMedGoogle Scholar
  73. 73.
    Schieffelbein CW Jr, Snider DE. Tuberculosis control among homeless populations. Arch Intern Med 1988;148:1843.PubMedCrossRefGoogle Scholar
  74. 74.
    Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Resp Dis 1967;95:729.PubMedGoogle Scholar
  75. 75.
    Leonard MK, Osterholt D, Kourbatova EV, et al. How many sputum specimens are necessary to diagnose pulmonary tuberculosis. Am J Infect Control 2005;33:58–61.PubMedCrossRefGoogle Scholar
  76. 76.
    Willcox PA, Potgieter PD, Bateman ED, et al. Rapid diagnosis of sputum-negative miliary tuberculosis using the flexible fiberoptic bronchoscope. Thorax 1986;41:681.PubMedCrossRefGoogle Scholar
  77. 77.
    Siddiqi SH, Libonati JP, Middlebrook G. Evaluation of a rapid radiometric method for drug susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 1981;13:908.PubMedGoogle Scholar
  78. 78.
    Daniel TM, Debanne SM. The serodiagnosis of tuberculosis and other mycobacterial diseases by enzyme-linked immunosorbent assay. Am Rev Respir Dis 1987;135:1137.PubMedGoogle Scholar
  79. 79.
    Ellner PD, Kiehn TE, Cammarata R, et al. Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods. J Clin Microbiol 1988;26:1349.PubMedGoogle Scholar
  80. 80.
    Eisenach KD, Cave MD, Bates JH, et al. Polymerase chain reaction amplification of a repetitive DNA sequence specific for Mycobacterium tuberculosis. J Infect Dis 1990;161:977.PubMedGoogle Scholar
  81. 81.
    Hermans PW, Schuitema AR, Van Soolinen D, et al. Specific detection of Mycobacterium tuberculosis complex strains by polymerase chain reaction. J Clin Microbiol 1990;28:1204.PubMedGoogle Scholar
  82. 82.
    Pao CC, Yen TSB, You JB, et al. Detection and identification of Mycobacterium tuberculosis by DNA amplification. J Clin Microbiol 1990;28:1877.PubMedGoogle Scholar
  83. 83.
    Mbulo GM, Kambashi BS, Kinkese J, et al. Comparison of two bacteriophage tests and nucleic acid amplification for the diagnosis of pulmonary tuberculosis in sub Saharan Africa. Int J Tuberc Lung Dis 2004;8:1342–1347.PubMedGoogle Scholar
  84. 84.
    Wang JY, Lee LN, Chou CS, et al. Performance assessment of a nested-PCR assay (the RAPID BA MTB) and the BD ProbeTec ET system for detection of Mycobacterium tuberculosis in clinical specimens. J Clin Microbiol 2004;10:4599–4603.CrossRefGoogle Scholar
  85. 85.
    American Thoracic Society/ Centers for Disease Control. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1986;134:355.Google Scholar
  86. 86.
    Quale JM, Lipschik GY, Heurich AE. Management of tuberculous pericarditis. Ann Thorac Surg 1987;43:653.PubMedCrossRefGoogle Scholar
  87. 87.
    Centers for Disease Control:The use of preventive therapy for tuberculous infection in the United States. MMWR Morb Mortal Wkly Rep 1990;39(RR-8):9.Google Scholar
  88. 88.
    Moran JF, Alexander LG, Staub EW, et al. Long-term results of pulmonary resection for atypical mycobacterial disease. Ann Thorac Surg 1983;35:597.PubMedCrossRefGoogle Scholar
  89. 89.
    Conlan AA, Hurwitz SS, Krige L, et al. Massive hemoptysis. J Thorac Cardiovasc Surg 1983;85:120.PubMedGoogle Scholar
  90. 90.
    Okabayashi K, Yamazaki K, Hamatake D, et al. Pleuropneumonectomy for pulmonary tuberculosis and chronic tuberculous empyema. Kyobu Geka 2004;57:1033–1037.PubMedGoogle Scholar
  91. 91.
    Takeda S, Maeda H, Hayakawa M, et al. Current surgical intervention for pulmonary tuberculosis. Ann Thorac Surg 2005;79:959–963.PubMedCrossRefGoogle Scholar
  92. 92.
    Timpe A, Runyon EH. The relationship of “atypical” acid-fast bacteria to human disease. J Lab Clin 1954;44:202.Google Scholar
  93. 93.
    Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959;43:273.PubMedGoogle Scholar
  94. 94.
    American Thoracic Society. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am Rev Respir Dis 1990;142:940.Google Scholar
  95. 95.
    McQuarrie DG, Hall WH. Actinomycosis of the lung and chest wall. Surgery 1968;64:905.PubMedGoogle Scholar
  96. 96.
    Palmer DL, Harvey RL, Wheeler JK. Diagnostic and therapeutic considerations in Nocardia asteroides infection. Medicine 1974;53:391.PubMedCrossRefGoogle Scholar
  97. 97.
    Buechner JA. Management of Fungus Diseases of the Lungs. Springfield, IL: Thomas; 1971.Google Scholar
  98. 98.
    Cole FH, Cole FH Jr, Khandekar A, et al. Management of broncholithiasis: is thoracotomy necessary? Ann Thorac Surg 1986;42:255.PubMedCrossRefGoogle Scholar
  99. 99.
    Goodwin RA Jr, Owens FT, Snell JD, et al. Chronic pulmonary histoplasmosis. Medicine 1976;55:413–452.PubMedCrossRefGoogle Scholar
  100. 100.
    Dines DE, Payne WS, Bernatz PE, et al. Mediastinal granuloma and fibrosing mediastinitis. Chest 1979;75:320.PubMedCrossRefGoogle Scholar
  101. 101.
    Maholtz, MS, Dauber JH, Yousem SA. Case report: fluconazole therapy in histoplasma mediastinal granuloma. Am J Med Sci 1994;307:274–277.PubMedCrossRefGoogle Scholar
  102. 102.
    Dunn EJ, Ulicny KS Jr, Wright CB, et al. Surgical implications of sclerosing mediastinitis. A report of six cases and review of the literature. Chest 1990;97:338–346.PubMedCrossRefGoogle Scholar
  103. 103.
    Urschel HC Jr, Razzuk MA, Netto GJ, et al. Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole. Ann Thorac Surg 1990;50:215–221.PubMedCrossRefGoogle Scholar
  104. 104.
    Garrett HE, Roper CL. Surgical intervention in histoplasmosis. Ann Thorac Surg 1986;42:711–722.PubMedCrossRefGoogle Scholar
  105. 105.
    Gilliland MD, Scott LD, Walker WE. Esophageal obstruction caused by mediastinal histoplasmosis: beneficial results of operation. Surgery 1984;95:59–62.PubMedGoogle Scholar
  106. 106.
    Doyle TP, Loyd JE, Robbins IM. Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis. Am J Respir Crit Care 2001;164:657–660.Google Scholar
  107. 107.
    Drutz DJ, Catanzaro A. Coccidioidmycosis. Part I. Am Rev Respir Dis 1978;117:559.PubMedGoogle Scholar
  108. 108.
    Drutz DJ, Catanzaro A. Coccidioidmyocosis. Part II. Am Rev Respir Dis 1978;117:727.PubMedGoogle Scholar
  109. 109.
    Hyde L. Coccidiodal pulmonary cavitations. Dis Chest 1968;54:213.Google Scholar
  110. 110.
    Nelson AR. The surgical treatment of pulmonary coccidioidomycosis. Curr Probl Surg 1974:1–48.Google Scholar
  111. 111.
    Klein BS, Vergeront JM, Weeks RJ, et al. Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med 1986;314:529.PubMedGoogle Scholar
  112. 112.
    Chapman SW, Bradsher RW Jr, Campbell GD Jr, et al. Practice guidelines for the management of patients with blastomycosis. Infectious Disease Society of America. Clin Infect Dis 2000;30:679–683.PubMedCrossRefGoogle Scholar
  113. 113.
    Yamada H, Kotaki H, Takahasi T. Recommendation for the treatment of fungal pneumonias. Expert Opin Pharmacother 2003;8:1241–1258.CrossRefGoogle Scholar
  114. 114.
    Hatcher CR Jr, Sehdeva J, Waters WC III, et al. Primary pulmonary cryptococcosis. J Thorac Cardivasc Surg 1971;61:39.Google Scholar
  115. 115.
    Malde B, Greenberger PA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 2004;25:S38–S39.PubMedGoogle Scholar
  116. 116.
    Karas A, Hankins JR, Attar S, et al. Pulmonary aspergillosis: an analysis of 41 patients. Ann Thorac Surg 1976;22:1.PubMedCrossRefGoogle Scholar
  117. 117.
    Varkey B, Rose HD. Pulmonary aspergilloma: a rational approach to treatment. Am J Med 1976;61:626.PubMedCrossRefGoogle Scholar
  118. 118.
    Daly RC, Pairolero PC, Piehler JM, et al. Pulmonary aspergilloma: results of surgical treatment. J Thorac Cardiovasc Surg 1986;92:981.PubMedGoogle Scholar
  119. 119.
    Chen JC, Chang YL, Luh SP, et al. Surgical treatment of pulmonary aspergilloma: a 28 year experience. Thorax 1997;52:810–813.PubMedGoogle Scholar
  120. 120.
    el Oakley R, Petrou M, Goldstraw P. Indications and outcome of surgery for pulmonary aspergilloma. Thorax 1997;52:753–754.CrossRefGoogle Scholar
  121. 121.
    Babatasi G, Massetti M, Chapelier A, et al. Surgical treatment of pulmonary aspergilloma: current outcome. J Thorac Cardiovasc Surg 200;119:906–912.Google Scholar
  122. 122.
    Kim YT, Kang MC, Sung SW, et al. Good long-term outcomes after surgical treatment of simple and complex pulmonary aspergilloma. Ann Thorac Surg 2005;79:294–298.PubMedCrossRefGoogle Scholar
  123. 123.
    Boucher HW, Groll AH, Chiou CC, et al. Newer systemic agents: pharmacokinetics, safety and efficacy. Drugs 2004;64:1997–2020.PubMedCrossRefGoogle Scholar
  124. 124.
    Herbrecht R. Voriconazole: therapeutic review of a new azole antifungal. Expert Rev Anti Infect Ther 2004;2:485–497.PubMedCrossRefGoogle Scholar
  125. 125.
    Perfect JR. Management of invasive mycoses in hematology patients: current approaches. Oncology 2004;18:5–14.PubMedGoogle Scholar
  126. 126.
    Perfect JR. Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology 2004;18:15–23.Google Scholar
  127. 127.
    Kontoyiannis DP, Lewis RE. Caspofungin versus liposomal amphotericin B for empirical therapy. N Engl J Med 2005;352:410–414.PubMedCrossRefGoogle Scholar
  128. 128.
    Temeck BK, Venzon DJ, Moskaluk CA. Thoracotomy for pulmonary mycoses in non-HIV immunosuppressed patients. Ann Thorac Surg 1994;58:333–338.PubMedCrossRefGoogle Scholar
  129. 129.
    Dunst KM, Mueller LC. Surgical management of bilateral multiple invasive pulmonary aspergillosis. J Thorac Cardiovasc Surg 2004;128:621–622.PubMedCrossRefGoogle Scholar
  130. 130.
    Matt P, Bernet F, Habicht J, Gambazzi F, et al. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia. Chest 2004;126:1783–1788.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Frank A. BaciewiczJr.
    • 1
  1. 1.Department of Cardio-Thoracic SurgeryWayne State University/Harper HospitalDetroitUSA

Personalised recommendations